Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03158428 · ClinicalTrials.gov registry record · NA

CSD170202: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

A NA study of Tobacco Use, sponsored by RAI Services Company.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT03158428 is a NA study of Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 55 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03158428, a NA study of Tobacco Use, has completed, sponsored by RAI Services Company.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate exposure to tobacco constituents from two moist snuff products, and provide a basis for comparing mouth-level exposure (MLE) in moist snuff users after use of each of the two moist snuff products.

Conditions Studied

Tobacco Use

Interventions

  • OTHER CSD170202AA
  • OTHER CSD170202AB

Study Locations (1)

Georgia

  • Clinical Research Atlanta - Stockbridge

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2017-05-08
Est. Completion 2017-07-25
Phase NA

Sponsor

RAI Services Company

42 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03158428

The ClinicalTrials.gov registry entry for NCT03158428 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (85% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which CSD170202AA is the first listed.

NCT03158428 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03158428 about?

NCT03158428 is a clinical study titled "CSD170202: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products". This study will evaluate exposure to tobacco constituents from two moist snuff products, and provide a basis for comparing mouth-level exposure (MLE) in moist snuff users after use of each of the two moist snuff products.

What is the current status of trial NCT03158428?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2017-05-08. Estimated completion is 2017-07-25.

What conditions does trial NCT03158428 study?

This clinical trial studies the following conditions: Tobacco Use.

What interventions are being tested in trial NCT03158428?

The interventions under investigation include: CSD170202AA (OTHER), CSD170202AB (OTHER).

Who is sponsoring clinical trial NCT03158428?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03158428 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.